Acurx Pharmaceuticals | RW: Registration Withdrawal Request
Apr 17 16:10 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Apr 3 21:59 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shawah Robert G.
Apr 3 21:59 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Apr 3 21:59 ET
Acurx Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 2 07:34 ET
Acurx Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Mar 29 17:03 ET
Acurx Pharmaceuticals | 8-K: Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Mar 18 16:23 ET
Acurx Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Mar 18 16:13 ET
Acurx Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 15 16:41 ET
Acurx Pharmaceuticals | 10-K: Annual report
Mar 15 16:14 ET
Acurx Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Feb 14 14:47 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl
Jan 22 00:00 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P
Jan 4 00:00 ET
Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J
Jan 4 00:00 ET
Acurx Pharmaceuticals | 8-K: Current report
Nov 15, 2023 17:02 ET
Acurx Pharmaceuticals | 424B5: Prospectus
Nov 15, 2023 16:49 ET
Acurx Pharmaceuticals | 8-K: Acurx Pharmaceuticals, Inc. Reports Third Quarter 2023 Results and Provides Business Update
Nov 14, 2023 16:05 ET
Acurx Pharmaceuticals: Q3 2023 Earnings Report
Nov 13, 2023 16:05 ET
Acurx Pharmaceuticals | 8-K: Current report
Nov 3, 2023 16:05 ET
Acurx Pharmaceuticals | 8-K: Current report
Oct 2, 2023 16:41 ET
No Data
No Data